1. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway
   TAO LI et al, 2016, Oncology Reports CrossRef
2. Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: a meta-analysis of publicly available microarray data sets
   Yang Sun et al, 2016, Tumor Biology CrossRef
3. Biological Basis of Treatment Failure
   Amritha Suresh et al, 2017, Contemporary Oral Oncology CrossRef
4. Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell GrowthviaInhibition of the ERK-Dependent EGF Receptor Signaling Pathway
   Dong Ju Son et al, 2015, BioMed Research International CrossRef
5. Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity
   Hamdan N. Alajami et al, 2022, Pharmaceutics CrossRef
6. Overcoming radioresistance in head and neck squamous cell carcinoma
   Vicky N. Yamamoto et al, 2016, Oral Oncology CrossRef
7. Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
   Walaa Nasry et al, 2018, Cancers CrossRef
8. The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma
   Yaqiong Yang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
9. Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy
   Federica Finetti et al, 2023, Cancers CrossRef
10. Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial–mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro
    Gennaro Altamura et al, 2024, Veterinary and Comparative Oncology CrossRef
11. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
    Wen-Jian Hu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma
    Qianting He et al, 2016, BMC Cancer CrossRef
13. Celecoxib in Cancer Therapy and Prevention – Review
    Natalia Tołoczko-Iwaniuk et al, 2019, Current Drug Targets CrossRef
14. Extracellular Prostaglandins E1 and E2 and Inflammatory Cytokines Are Regulated by the Senescence Program in Potentially Premalignant Oral Keratinocytes
    Lee Peng Karen-Ng et al, 2022, Cancers CrossRef
15. Cyclooxygenase and CD147 expression in oral squamous cell carcinoma patient samples and cell lines
    Walaa Hamed Shaker Nasry et al, 2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
16. Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells
    Bharath Kumar Velmurugan et al, 2020, Biotechnic & Histochemistry CrossRef
17. Progress in targeted therapeutic drugs for oral squamous cell carcinoma
    Lian Liu et al, 2019, Surgical Oncology CrossRef
18. The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β-catenin signaling axis
    Araceli Valverde et al, 2017, Oncotarget CrossRef
19. Eicosanoids and HB-EGF/EGFR in cancer
    Cheng-Chieh Yang et al, 2018, Cancer and Metastasis Reviews CrossRef
20. Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia
    Xibing Zhuang et al, 2023, Journal of Translational Medicine CrossRef
21. Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2
    Ying-Ju Chen et al, 2016, Oncology Letters CrossRef